These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 11322758)

  • 21. Deleted in colorectal carcinoma (DCC) binds heparin via its fifth fibronectin type III domain.
    Bennett KL; Bradshaw J; Youngman T; Rodgers J; Greenfield B; Aruffo A; Linsley PS
    J Biol Chem; 1997 Oct; 272(43):26940-6. PubMed ID: 9341129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the heparin-binding site of the osteoinductive protein NELL1 by site-directed mutagenesis.
    Takahashi K; Imai A; Iijima M; Yoshimoto N; Maturana AD; Kuroda S; Niimi T
    FEBS Lett; 2015 Dec; 589(24 Pt B):4026-32. PubMed ID: 26627376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of heparin-binding amino acid residues in antibody HS4C3 with the potential to design antibodies against heparan sulfate domains.
    Damen LAA; Bui TP; van Wessel T; Li Y; Straten BF; Pampiermole R; Daamen WF; Fernig DG; van Kuppevelt TH
    Glycobiology; 2024 Jun; 34(8):. PubMed ID: 38963938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a heparin-binding region of rat thyroglobulin involved in megalin binding.
    Marinò M; Friedlander JA; McCluskey RT; Andrews D
    J Biol Chem; 1999 Oct; 274(43):30377-86. PubMed ID: 10521414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein.
    Luria-Pérez R; Candelaria PV; Daniels-Wells TR; Rodríguez JA; Helguera G; Penichet ML
    Cytokine; 2019 Aug; 120():220-226. PubMed ID: 31121497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.
    Lietha D; Chirgadze DY; Mulloy B; Blundell TL; Gherardi E
    EMBO J; 2001 Oct; 20(20):5543-55. PubMed ID: 11597998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation.
    Sadir R; Forest E; Lortat-Jacob H
    J Biol Chem; 1998 May; 273(18):10919-25. PubMed ID: 9556569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of the heparin binding site of follistatin.
    Inouye S; Ling N; Shimasaki S
    Mol Cell Endocrinol; 1992 Dec; 90(1):1-6. PubMed ID: 1301390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a heparin binding domain of the neural cell adhesion molecule N-CAM using synthetic peptides.
    Cole GJ; Akeson R
    Neuron; 1989 Feb; 2(2):1157-65. PubMed ID: 2624745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19.
    de Fougerolles AR; Batista F; Johnsson E; Fearon DT
    Eur J Immunol; 2001 Jul; 31(7):2189-99. PubMed ID: 11449373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule.
    Lortat-Jacob H; Grimaud JA
    FEBS Lett; 1991 Mar; 280(1):152-4. PubMed ID: 1901275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nature of the conserved basic amino acid sequences found among 437 heparin binding proteins determined by network analysis.
    Rudd TR; Preston MD; Yates EA
    Mol Biosyst; 2017 May; 13(5):852-865. PubMed ID: 28317949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites.
    Najjam S; Mulloy B; Theze J; Gordon M; Gibbs R; Rider CC
    Glycobiology; 1998 May; 8(5):509-16. PubMed ID: 9597549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site.
    Zhou H; Mazzulla MJ; Kaufman JD; Stahl SJ; Wingfield PT; Rubin JS; Bottaro DP; Byrd RA
    Structure; 1998 Jan; 6(1):109-16. PubMed ID: 9493272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of heparin-binding protein HBp17 and identification of HBp17 heparin binding site.
    Wang XC; Chen JH; Crab JW; Sato JD
    Biochem Mol Biol Int; 1998 Sep; 46(1):81-7. PubMed ID: 9784842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unraveling the amino acid sequence crucial for heparin binding to collagen V.
    Delacoux F; Fichard A; Cogne S; Garrone R; Ruggiero F
    J Biol Chem; 2000 Sep; 275(38):29377-82. PubMed ID: 10862775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orientation of heparin-binding sites in native vitronectin. Analyses of ligand binding to the primary glycosaminoglycan-binding site indicate that putative secondary sites are not functional.
    Gibson AD; Lamerdin JA; Zhuang P; Baburaj K; Serpersu EH; Peterson CB
    J Biol Chem; 1999 Mar; 274(10):6432-42. PubMed ID: 10037735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting human epidermal growth factor receptor signaling with the neuregulin's heparin-binding domain.
    Ma Z; Li Q; An H; Pankonin MS; Wang J; Loeb JA
    J Biol Chem; 2009 Nov; 284(46):32108-15. PubMed ID: 19717564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and kinetics analysis of a novel heparin-binding site (KEDK) in human tenascin-C.
    Jang JH; Hwang JH; Chung CP; Choung PH
    J Biol Chem; 2004 Jun; 279(24):25562-6. PubMed ID: 15069070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased heparin binding by site directed mutagenesis of a recombinant chimera of bombyxin and insulin-like growth factor II.
    Congote LF
    Biochim Biophys Acta; 1995 Apr; 1243(3):538-42. PubMed ID: 7727531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.